After internal setbacks, Pfizer buys obesity player Metsera
Pfizer's answer to a string of disappointing projects in obesity R&D? Bolt on a promising pipeline from another developer.
Bayer starts pivotal Parkinson's cell therapy trial
Bayer's much-anticipated stem cell therapy for Parkinson's disease is gathering momentum, with dosing in phase 3 trials now underway.
Stealth's patience rewarded as FDA approves Barth drug
After a long haul, Stealth BioTherapeutics has finally claimed FDA approval for Forzinity, the first treatment for ultra-rare disease Barth syndrome.
FDA clears subcutaneous Keytruda in a boost to MSD
MSD's Keytruda will soon be available as a subcutaneous injection, improving convenience for patients and defending it from a looming patent loss.
COVID-19 vaccine support reined back by ACIP
The CDC's vaccine committee reduced some support for COVID-19 vaccines, but did not go as far as some might have feared in limiting access.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
Innovating Disease-Modifying Neurodegenerative Therapies to ...
Discovering, Translating & Clinically Advancing Novel Targets
4th LNP Immunogenicity & Toxicity Summit
Assessing LNP Immunogenicity & Toxicity to Effectively Monitor Clinical Safety & Ensure Regulatory Compliance for Novel Therapeutics & Vaccines
Itching for derm progress? We’ve got the cure.
Join 120+ peers at the 9th Dermatology Drug Development Summit
2nd ADC Pharmacokinetics & Clinical Pharmacology Summit
Bringing together leaders in PKPD, bioanalysis, pharmacometrics, and clinical pharmacology
6th Gene Therapy for Ophthalmic Disorders Summit | Don’t Tur...
Restoring Vision through Genetic Medicine